Terms: = Prostate cancer AND BTG1, P62324, 694, ENSG00000133639
87 results:
1. Neighborhood Deprivation, Race and Ethnicity, and prostate cancer Outcomes Across California Health Care Systems.
Wadhwa A; Roscoe C; Duran EA; Kwan L; Haroldsen CL; Shelton JB; Cullen J; Knudsen BS; Rettig MB; Pyarajan S; Nickols NG; Maxwell KN; Yamoah K; Rose BS; Rebbeck TR; Iyer HS; Garraway IP
JAMA Netw Open; 2024 Mar; 7(3):e242852. PubMed ID: 38502125
[TBL] [Abstract] [Full Text] [Related]
2. Carbohydrate quality, not quantity, linked to reduced colorectal cancer incidence and mortality in US populations: evidence from a prospective study.
Xiao Y; Xiang L; Jiang Y; Tang Y; Gu H; Wang Y; Peng L
BMC Med; 2024 Mar; 22(1):97. PubMed ID: 38443943
[TBL] [Abstract] [Full Text] [Related]
3. Non-medical interventions to enhance return to work for people with cancer.
de Boer AG; Tamminga SJ; Boschman JS; Hoving JL
Cochrane Database Syst Rev; 2024 Mar; 3(3):CD007569. PubMed ID: 38441440
[TBL] [Abstract] [Full Text] [Related]
4. Prediction of Gleason score in prostate cancer patients based on radiomic features of transrectal ultrasound images.
Cheng T; Li H
Br J Radiol; 2024 Feb; 97(1154):415-421. PubMed ID: 38308030
[TBL] [Abstract] [Full Text] [Related]
5. Association between sociodemographic factors and diagnosis of lethal prostate cancer in early life.
Smani S; Novosel M; Sutherland R; Jeong F; Jalfon M; Marks V; Rajwa P; Nolazco JI; Washington SL; Renzulli JF; Sprenkle P; Kim IY; Leapman MS
Urol Oncol; 2024 Feb; 42(2):28.e9-28.e20. PubMed ID: 38161105
[TBL] [Abstract] [Full Text] [Related]
6. Real-world use of antiretroviral therapy and risk of cancer among people with HIV in Texas.
Horner MJ; Shiels MS; McNeel TS; Monterosso A; Miller P; Pfeiffer RM; Engels EA
AIDS; 2024 Mar; 38(3):379-386. PubMed ID: 37890463
[TBL] [Abstract] [Full Text] [Related]
7. Patient-related characteristics predict prostate cancers in men with PI-RADS 4-5 to further optimize the diagnostic performance of MRI.
Xiang L; Ma S; Xu Y; Jiang L; Guo H; Liu H; Liu Y
Abdom Radiol (NY); 2023 Dec; 48(12):3766-3773. PubMed ID: 37776336
[TBL] [Abstract] [Full Text] [Related]
8. Quality assessment of prostate MRI by PI-QUAL score: Inter-reader agreement and impact on prostate cancer local staging at 3 Tesla.
Coelho FMA; Amaral LTW; Mitsutake LKN; Mussi TC; Baroni RH
Eur J Radiol; 2023 Aug; 165():110921. PubMed ID: 37336037
[TBL] [Abstract] [Full Text] [Related]
9. Genetically proxied glucose-lowering drug target perturbation and risk of cancer: a Mendelian randomisation analysis.
Yarmolinsky J; Bouras E; Constantinescu A; Burrows K; Bull CJ; Vincent EE; Martin RM; Dimopoulou O; Lewis SJ; Moreno V; Vujkovic M; Chang KM; Voight BF; Tsao PS; Gunter MJ; Hampe J; Pellatt AJ; Pharoah PDP; Schoen RE; Gallinger S; Jenkins MA; Pai RK; ; ; Gill D; Tsilidis KK
Diabetologia; 2023 Aug; 66(8):1481-1500. PubMed ID: 37171501
[TBL] [Abstract] [Full Text] [Related]
10. Polygenic risk scores for the prediction of common cancers in East Asians: A population-based prospective cohort study.
Ho PJ; Tan IB; Chong DQ; Khor CC; Yuan JM; Koh WP; Dorajoo R; Li J
Elife; 2023 Mar; 12():. PubMed ID: 36971353
[TBL] [Abstract] [Full Text] [Related]
11. Routine practice data of three cancer entities: Comparison among cancer registry and health insurance data.
Lang LM; Behr C; Ludwig M; Walker J; Christian Lange H; Basedow F; Justenhoven C
Z Evid Fortbild Qual Gesundhwes; 2023 Apr; 177():65-72. PubMed ID: 36804770
[TBL] [Abstract] [Full Text] [Related]
12. Comparative proteomics reveals anticancer compounds from Lansium domesticum against NSCLC cells target mitochondrial processes.
Alvarez MR; De Juan F; Zhou Q; Dimzon IKD; Grijaldo SJ; Sunga S; Heralde F; Lebrilla CB; Completo GC; Nacario RC
Cell Biochem Funct; 2023 Mar; 41(2):166-176. PubMed ID: 36606472
[TBL] [Abstract] [Full Text] [Related]
13. Prognostic significance of pretreatment systemic immune-inflammation index in patients with prostate cancer: a meta-analysis.
Zhang B; Xu T
World J Surg Oncol; 2023 Jan; 21(1):2. PubMed ID: 36600256
[TBL] [Abstract] [Full Text] [Related]
14. Magnetic Resonance Imaging-based T-staging to Predict Biochemical Recurrence after Radical prostatectomy: A Step Towards the iTNM Classification.
Baboudjian M; Gondran-Tellier B; Touzani A; Martini A; Diamand R; Roche JB; Lacetera V; Beauval JB; Roumeguère T; Simone G; Benamran D; Fourcade A; Fiard G; van den Bergh RCN; Peltier A; Ploussard G
Eur Urol Oncol; 2023 Aug; 6(4):406-413. PubMed ID: 36280445
[TBL] [Abstract] [Full Text] [Related]
15. A systematic review and meta-analysis on non-metastatic castration resistant prostate cancer: The radiation oncologist's perspective.
Ingrosso G; Bottero M; Becherini C; Caini S; Alì E; Lancia A; Ost P; Sanguineti G; Siva S; Zilli T; Francolini G; Bellavita R; Aristei C; Livi L; Detti B
Semin Oncol; 2022 Oct; 49(5):409-418. PubMed ID: 36192243
[TBL] [Abstract] [Full Text] [Related]
16. Free PSA performs better than total PSA in predicting prostate volume in Chinese men with PSA levels of 2.5-9.9 ng ml
Huang MP; Tang P; Klein CS; Wei XH; Du W; Fu JG; Huang TH; Chen H; Xie KJ
Asian J Androl; 2023; 25(1):82-85. PubMed ID: 35562126
[TBL] [Abstract] [Full Text] [Related]
17. New model of PIRADS and adjusted prostatespecific antigen density of peripheral zone improves the detection rate of initial prostate biopsy: a diagnostic study.
Huang C; Cai ZQ; Qiu F; Pu JX; Xi QL; Wei XD; Wang XM; Zhao XJ; Guo LC; Hou JQ; Huang YH
Asian J Androl; 2023; 25(1):126-131. PubMed ID: 35488668
[TBL] [Abstract] [Full Text] [Related]
18. Post-MRI transrectal micro-ultrasonography of transition zone PI-RADS > 2 lesions for biopsy guidance.
Cornud F; Lefevre A; Camparo P; Barat M; Dumonceau O; Galiano M; Flam T; Soyer P; Barral M
Eur Radiol; 2022 Nov; 32(11):7504-7512. PubMed ID: 35451606
[TBL] [Abstract] [Full Text] [Related]
19. [PI-RADS score of prostate multi-parametric magnetic resonance imaging predicts pathological features of prostate cancer: An imaging to whole-mount pathology matching study].
Gao J; Wang BJ; Zhang Q; Zhao XZ; Fu Y; Li DY; Wang W; Guo HQ
Zhonghua Nan Ke Xue; 2022 Mar; 28(3):217-222. PubMed ID: 37462959
[TBL] [Abstract] [Full Text] [Related]
20. Comparative oncological outcomes after radical prostatectomy or external beam radiation therapy plus androgen deprivation therapy in men with clinical T3b prostate cancer.
Lee W; Lim B; Kyung YS; Kim CS
Int J Urol; 2022 May; 29(5):414-420. PubMed ID: 35133691
[TBL] [Abstract] [Full Text] [Related]
[Next]
